BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29355432)

  • 1. An update on the treatment of pediatric-onset Langerhans cell histiocytosis through pharmacotherapy.
    Minkov M
    Expert Opin Pharmacother; 2018 Feb; 19(3):233-242. PubMed ID: 29355432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multisystem Langerhans cell histiocytosis in children: current treatment and future directions.
    Minkov M
    Paediatr Drugs; 2011 Apr; 13(2):75-86. PubMed ID: 21351807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis.
    Gadner H; Grois N; Arico M; Broadbent V; Ceci A; Jakobson A; Komp D; Michaelis J; Nicholson S; Pötschger U; Pritchard J; Ladisch S;
    J Pediatr; 2001 May; 138(5):728-34. PubMed ID: 11343051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
    Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
    Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society.
    Ladisch S; Gadner H; Aricò M; Broadbent V; Grois N; Jacobson A; Komp D; Nicholson HS
    Med Pediatr Oncol; 1994; 23(2):107-10. PubMed ID: 8202031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of adult multisystemic Langerhans cell histiocytosis with psoralen-UV-A, prednisolone, mercaptopurine, and vinblastine.
    von Stebut E; Schadmand-Fischer S; Bräuninger W; Kreft A; Doberauer C; Steinbrink K
    Arch Dermatol; 2008 May; 144(5):649-53. PubMed ID: 18490592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Langerhans cell histiocytosis presenting as hypothyroid goitre: a unique presentation.
    Marupudi KC; Karanth SS; Thomas J
    BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25465459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study.
    Tazi A; Lorillon G; Haroche J; Neel A; Dominique S; Aouba A; Bouaziz JD; de Margerie-Melon C; Bugnet E; Cottin V; Comont T; Lavigne C; Kahn JE; Donadieu J; Chevret S
    Orphanet J Rare Dis; 2017 May; 12(1):95. PubMed ID: 28532436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Langerhans cell histiocytosis with a modified risk-adapted protocol-experience from a tertiary cancer institute in India.
    Narula G; Pradhan ND; Arora B; Banavali SD
    Pediatr Blood Cancer; 2018 Aug; 65(8):e27028. PubMed ID: 29512864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy.
    Héritier S; Emile JF; Barkaoui MA; Thomas C; Fraitag S; Boudjemaa S; Renaud F; Moreau A; Peuchmaur M; Chassagne-Clément C; Dijoud F; Rigau V; Moshous D; Lambilliotte A; Mazingue F; Kebaili K; Miron J; Jeziorski E; Plat G; Aladjidi N; Ferster A; Pacquement H; Galambrun C; Brugières L; Leverger G; Mansuy L; Paillard C; Deville A; Armari-Alla C; Lutun A; Gillibert-Yvert M; Stephan JL; Cohen-Aubart F; Haroche J; Pellier I; Millot F; Lescoeur B; Gandemer V; Bodemer C; Lacave R; Hélias-Rodzewicz Z; Taly V; Geissmann F; Donadieu J
    J Clin Oncol; 2016 Sep; 34(25):3023-30. PubMed ID: 27382093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X).
    Viana MB; Oliveira BM; Silva CM; Rios Leite VH
    Med Pediatr Oncol; 1991; 19(4):289-94. PubMed ID: 1669481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
    Morimoto A; Shioda Y; Imamura T; Kudo K; Kawaguchi H; Sakashita K; Yasui M; Koga Y; Kobayashi R; Ishii E; Fujimoto J; Horibe K; Bessho F; Tsunematsu Y; Imashuku S
    Int J Hematol; 2016 Jul; 104(1):99-109. PubMed ID: 27040279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
    Morimoto A; Shioda Y; Imamura T; Kudo K; Kitoh T; Kawaguchi H; Goto H; Kosaka Y; Tsunematsu Y; Imashuku S;
    Int J Hematol; 2018 Aug; 108(2):192-198. PubMed ID: 29594922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment results of Langerhans cell histiocytosis with LSH II protocol].
    Mottl H; Ganevová M; Radvanská J; Chánová M; Smelhaus V; Kodet R; Mrhalová M; Tichý M
    Cas Lek Cesk; 2005; 144(11):753-5. PubMed ID: 16335702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator.
    Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H;
    Med Pediatr Oncol; 2002 Dec; 39(6):581-5. PubMed ID: 12376981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful Treatment of Refractory Langerhans Cell Histiocytosis of the Choroid Plexus in a Child With Pulse Dexamethasone and Lenalidomide.
    Uppuluri R; Ramachandrakurup S; Balaji R; Subburaj D; Bakane A; Raj R
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):e74-e78. PubMed ID: 28099396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Langerhans cell histiocytosis in children: History, classification, pathobiology, clinical manifestations, and prognosis.
    Krooks J; Minkov M; Weatherall AG
    J Am Acad Dermatol; 2018 Jun; 78(6):1035-1044. PubMed ID: 29754885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug therapy for the treatment of Langerhans cell histiocytosis.
    McClain KL
    Expert Opin Pharmacother; 2005 Nov; 6(14):2435-41. PubMed ID: 16259575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult Langerhans cell histiocytosis in a middle aged Ethiopian woman.
    Idriss MH; Temam F; Woldeyes M
    Ethiop Med J; 2012 Apr; 50(2):193-200. PubMed ID: 22924288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rare disorder mimics otitis media: Langerhans cell histiocytosis of the temporal bone in a child with interstitial pulmonary fibrosis.
    Xie SM; Liu W; Xiang YY; Xiao ZA; Ren HM; Peng AQ; Wu WJ; Yang XM; Xie DH; Yin TF; Ren JH
    Am J Otolaryngol; 2014; 35(6):816-21. PubMed ID: 25139821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.